Halia Therapeutics, Inc.

Halia Therapeutics, Inc. company information, Employees & Contact Information

Explore related pages

Halia Therapeutics, Inc. email format Halia Therapeutics, Inc. management contacts

Related company profiles:

Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.

Company Details

Employees
24
Founded
-
Address
3900 N Traverse Mountain Blvd, Lehi,utah 84043,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
https://haliatx.com/
Keywords
BioHive Utah.
HQ
Lehi, Utah
Competitors
Seek Labs, IROS CRO, Wasatch Biolabs, Biolexis Therapeutics, Inc., BioHive Utah, Recursion, Renew Biotechnologies, BioUtah, Altitude Lab, Rebel Medicine.
Looking for a particular Halia Therapeutics, Inc. employee's phone or email?

Halia Therapeutics, Inc. Questions

News

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - Laotian Times

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Laotian Times

Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation - Yahoo Finance

Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation Yahoo Finance

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets - PR Newswire UK

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets PR Newswire UK

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes - StreetInsider

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes StreetInsider

Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics - PR Newswire

Halia Therapeutics Announces $30M Series C Financing to Advance Novel Pipeline of Anti-Inflammatory Therapeutics PR Newswire

Companies like Halia Therapeutics, Inc.

Recursion logo - Similar company to Halia Therapeutics, Inc.

Recursion

846
BioUtah logo - Similar company to Halia Therapeutics, Inc.

Bioutah

11
Biolexis Therapeutics, Inc. logo - Similar company to Halia Therapeutics, Inc.

Biolexis Therapeutic...

15
Wasatch Biolabs logo - Similar company to Halia Therapeutics, Inc.

Wasatch Biolabs

17
IROS CRO logo - Similar company to Halia Therapeutics, Inc.

Iros Cro

27
BioHive Utah logo - Similar company to Halia Therapeutics, Inc.

Biohive Utah

16
Altitude Lab logo - Similar company to Halia Therapeutics, Inc.

Altitude Lab

4
Seek Labs logo - Similar company to Halia Therapeutics, Inc.

Seek Labs

40
Rebel Medicine logo - Similar company to Halia Therapeutics, Inc.

Rebel Medicine

12
Renew Biotechnologies logo - Similar company to Halia Therapeutics, Inc.

Renew Biotechnologies

19

Top Halia Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant